Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lenvatinib”

516 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 516 results

Testing effectiveness (Phase 2)Study completedNCT03477175
What this trial is testing

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Who this might be right for
Solid Tumors
Eisai Inc. 40
Testing effectiveness (Phase 2)UnknownNCT06030934
What this trial is testing

Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Fudan University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06232564
What this trial is testing

Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs

Who this might be right for
Neuroendocrine Tumors
Imperial College London 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Testing effectiveness (Phase 2)Looking for participantsNCT06420440
What this trial is testing

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

Who this might be right for
HCC
Chen Xiaoping 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT05114421
What this trial is testing

Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients

Who this might be right for
High Grade Fallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaPeritoneal High Grade Serous Adenocarcinoma+3 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05170438
What this trial is testing

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment

Who this might be right for
Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan 51
Large-scale testing (Phase 3)Active Not RecruitingNCT04523493
What this trial is testing

Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Shanghai Junshi Bioscience Co., Ltd. 530
Testing effectiveness (Phase 2)Looking for participantsNCT07530445
What this trial is testing

Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer

Who this might be right for
Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer
Sun Yat-sen University 40
Very early researchStudy completedNCT02998775
What this trial is testing

Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding

Who this might be right for
Hepatic Impairment; Renal Impairment
Eisai Inc. 54
Testing effectiveness (Phase 2)Looking for participantsNCT05057845
What this trial is testing

Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Fudan University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04662710
What this trial is testing

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

Who this might be right for
Advanced/Metastatic Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLC 895
Testing effectiveness (Phase 2)Looking for participantsNCT06035224
What this trial is testing

Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
RenJi Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01728623
What this trial is testing

E7080 in Subjects With Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Eisai Co., Ltd. 51
Large-scale testing (Phase 3)Active Not RecruitingNCT05899049
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 249
Large-scale testing (Phase 3)UnknownNCT04319484
What this trial is testing

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusLiver Transplantation
RenJi Hospital 108
Testing effectiveness (Phase 2)UnknownNCT05823987
What this trial is testing

Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)

Who this might be right for
Advanced Biliary Tract Cancer
Fudan University 25
Not applicableLooking for participantsNCT07408804
What this trial is testing

Comparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)
Bangladesh Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06230471
What this trial is testing

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital 60
Very early researchLooking for participantsNCT05733715
What this trial is testing

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 30
Load More Results